MAIONE, Federica
 Distribuzione geografica
Continente #
NA - Nord America 2.105
EU - Europa 1.096
AS - Asia 886
AF - Africa 36
SA - Sud America 17
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.158
Nazione #
US - Stati Uniti d'America 2.057
CN - Cina 544
IT - Italia 383
FR - Francia 136
DE - Germania 121
GB - Regno Unito 111
JP - Giappone 62
CZ - Repubblica Ceca 61
VN - Vietnam 53
IN - India 51
NL - Olanda 47
CA - Canada 45
HK - Hong Kong 42
RU - Federazione Russa 41
KR - Corea 40
PL - Polonia 31
CH - Svizzera 25
ZA - Sudafrica 24
AT - Austria 21
UA - Ucraina 20
TW - Taiwan 17
FI - Finlandia 16
AU - Australia 15
SE - Svezia 15
ES - Italia 14
SG - Singapore 14
UZ - Uzbekistan 14
IE - Irlanda 13
RO - Romania 11
IR - Iran 10
BR - Brasile 8
BE - Belgio 7
TR - Turchia 7
CL - Cile 6
EG - Egitto 6
HU - Ungheria 6
NO - Norvegia 6
AE - Emirati Arabi Uniti 4
IL - Israele 4
PH - Filippine 4
SA - Arabia Saudita 4
TH - Thailandia 4
MX - Messico 3
CO - Colombia 2
DK - Danimarca 2
DZ - Algeria 2
GR - Grecia 2
ID - Indonesia 2
IQ - Iraq 2
JO - Giordania 2
KE - Kenya 2
MY - Malesia 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BT - Bhutan 1
CI - Costa d'Avorio 1
EU - Europa 1
GH - Ghana 1
HR - Croazia 1
KW - Kuwait 1
LT - Lituania 1
LV - Lettonia 1
PT - Portogallo 1
RS - Serbia 1
Totale 4.158
Città #
Fairfield 220
Houston 149
Seattle 140
Santa Cruz 132
Ashburn 123
Buffalo 99
Wilmington 97
Woodbridge 96
Cambridge 94
Ann Arbor 89
Shanghai 84
Torino 81
Beijing 55
Dong Ket 40
Milan 40
Guangzhou 36
Wuhan 36
Turin 34
Warsaw 31
University Park 29
Pisa 27
Nanjing 25
Garden Grove 24
Hangzhou 24
Los Angeles 24
San Diego 22
Chicago 21
Xian 21
Mountain View 18
Muizenberg 18
Las Vegas 17
Riva 17
Toronto 17
Vienna 17
Rome 16
Bengaluru 15
Paris 15
Bukhara 14
Central 14
Central District 14
Council Bluffs 14
Garching 14
Dublin 13
Jinan 13
New York 13
Ottawa 13
Taipei 13
Nanning 12
New Orleans 12
Phoenix 12
Chengdu 11
Chongqing 11
Clearwater 11
Shenyang 11
Tokyo 11
Helsinki 10
Lake Forest 9
Orsay 9
San Francisco 9
San Jose 9
Des Moines 8
Hamilton 8
Henderson 8
London 8
Mumbai 8
Nürnberg 8
Zhengzhou 8
Zurich 8
Amsterdam 7
Boston 7
Changchun 7
Changsha 7
Dallas 7
Florence 7
Fuzhou 7
Barcelona 6
Boardman 6
Brescia 6
Duncan 6
Leipzig 6
Seoul 6
Suzhou 6
Voulangis 6
Absecon 5
Atlanta 5
Beaverton 5
Cardiff 5
Cheyenne 5
East Setauket 5
Kameino 5
Liverpool 5
New Kensington 5
Oerlikon 5
Pittsburgh 5
Rotterdam 5
Westbury 5
Bradford 4
Collegno 4
Columbus 4
Dundee 4
Totale 2.557
Nome #
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth, file e27ce42c-7e04-2581-e053-d805fe0acbaa 749
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor., file e27ce427-ad2c-2581-e053-d805fe0acbaa 419
Design and synthesis of encorafenib-based BRAF-V600E degraders, file d8e03593-a5c7-4f96-9d2b-d9bc3af47ed2 234
SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers, file e27ce429-c0de-2581-e053-d805fe0acbaa 208
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform., file e27ce426-daf1-2581-e053-d805fe0acbaa 200
Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling, file e27ce42a-c382-2581-e053-d805fe0acbaa 199
Nucleolin targeting impairs the progression of pancreatic cancer and promotes the normalization of tumor vasculature, file e27ce42c-9a05-2581-e053-d805fe0acbaa 193
Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody-“decoy” strategy, file e27ce42e-5f09-2581-e053-d805fe0acbaa 188
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination, file e27ce427-00cf-2581-e053-d805fe0acbaa 172
α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis, file e27ce42c-cfbd-2581-e053-d805fe0acbaa 169
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice, file e27ce427-b559-2581-e053-d805fe0acbaa 164
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity, file e27ce429-5269-2581-e053-d805fe0acbaa 152
Class 3 semaphorins in cardiovascular development, file e27ce429-d82c-2581-e053-d805fe0acbaa 144
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent, file e27ce42d-6655-2581-e053-d805fe0acbaa 136
Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia, file e27ce426-e4f1-2581-e053-d805fe0acbaa 130
CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth, file e27ce430-afd1-2581-e053-d805fe0acbaa 116
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance, file e27ce430-deb4-2581-e053-d805fe0acbaa 114
Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program, file e27ce42c-5624-2581-e053-d805fe0acbaa 94
NCL targeting impairs the progression of pancreatic ductal adenocarcinoma and promotes tumor vessel normalization through Ang-2 inhibition, file e27ce431-d181-2581-e053-d805fe0acbaa 92
Semaphorin 3A normalizes the tumor vasculature and impairs tumor progression in a Nrp-1-independent manner, file e27ce431-d183-2581-e053-d805fe0acbaa 90
HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction, file e27ce431-ed1e-2581-e053-d805fe0acbaa 74
Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy, file e27ce42d-4b85-2581-e053-d805fe0acbaa 66
Osteopontin binds ICOSL promoting tumor metastasis, file e27ce431-66df-2581-e053-d805fe0acbaa 64
Proteomics-based metabolic modelling reveals that fatty acid oxidation controls endothelial cell permeability., file e27ce429-2a97-2581-e053-d805fe0acbaa 60
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression, file fa14c902-131c-4603-a4d2-23ed97a4cad4 20
Nucleolin targeting impairs the progression of pancreatic cancer and promotes the normalization of tumor vasculature, file e27ce432-4a3d-2581-e053-d805fe0acbaa 19
Neuropilin 1 and its inhibitory ligand mini-tryptophanyl-tRNA synthetase inversely regulate VE-cadherin turnover and vascular permeability, file 3c64135f-5ed1-4b51-b6e9-afaab6c77b52 11
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein, file d8cded6f-e57e-4e8c-87da-877e19c5510e 11
Proteomics-based metabolic modelling reveals that fatty acid oxidation controls endothelial cell permeability., file e27ce427-dab3-2581-e053-d805fe0acbaa 7
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth, file e27ce42c-77f6-2581-e053-d805fe0acbaa 7
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression, file 8d5c83bc-ca94-462b-bcbb-0bda8b642def 6
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression, file 87b4a0af-4fb6-41bd-96e2-b20447cd1e45 5
The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway, file b3425c6f-9300-4681-935d-21bf3dbec3fb 5
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent, file e27ce42d-736a-2581-e053-d805fe0acbaa 3
Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models, file e27ce42d-4b81-2581-e053-d805fe0acbaa 2
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent, file e27ce432-515e-2581-e053-d805fe0acbaa 2
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models, file 7408d2ea-9bcd-4763-a5c8-f33d578565e7 1
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth, file e27ce432-4e12-2581-e053-d805fe0acbaa 1
Totale 4.327
Categoria #
all - tutte 6.746
article - articoli 0
book - libri 0
conference - conferenze 786
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.532


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019245 0 0 0 0 0 0 0 0 0 54 113 78
2019/2020833 76 45 40 92 62 69 74 85 76 79 59 76
2020/2021891 47 63 58 82 86 56 82 76 89 93 78 81
2021/20221.012 97 82 55 130 109 40 79 64 62 61 159 74
2022/2023660 20 48 154 79 37 94 65 38 39 35 43 8
2023/2024303 30 27 29 39 22 17 61 55 6 17 0 0
Totale 4.327